Ozempic gastroparesis lawsuit claims are growing rapidly across the United States. If you developed stomach paralysis after taking Ozempic, Wegovy, or another GLP-1 receptor agonist medication, you may qualify for significant compensation. Gastroparesis is a devastating condition that affects your stomach’s ability to empty food normally. For patients already struggling with this diagnosis, learning it may have been caused by a prescription medication adds frustration and anger. You deserve answers about what happened to your body.
Understanding Ozempic Gastroparesis Lawsuit: Why This Group Is at Risk
Semaglutide, the active ingredient in Ozempic and Wegovy, works by slowing gastric emptying. This mechanism helps control blood sugar and reduce appetite. However, for thousands of patients, the slowing went too far. Their stomachs essentially stopped functioning normally. The FDA added “delayed gastric emptying” as an adverse event to the semaglutide label in November 2024. The current label now states semaglutide is “not recommended in patients with severe gastroparesis.”
Gastroparesis patients in this litigation face unique challenges. Many were prescribed Ozempic for Type 2 diabetes management. They trusted their doctors. They trusted the manufacturer. Novo Nordisk knew semaglutide delays gastric emptying. Yet the company failed to adequately warn patients and physicians about the risk of permanent stomach paralysis. The Ozempic gastroparesis lawsuit alleges this failure caused preventable suffering.
Symptoms of drug-induced gastroparesis include severe nausea, vomiting, abdominal pain, and dangerous weight loss. Some patients require feeding tubes. Others face repeated hospitalizations. Many cannot eat solid food for months or years. These injuries go far beyond typical medication side effects. They represent life-altering harm that demands accountability.
Active Lawsuits Affecting This Group
The primary Ozempic gastroparesis lawsuit litigation is consolidated in MDL 3094. This multidistrict litigation is titled “In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation.” It is pending in the U.S. District Court for the Eastern District of Pennsylvania. Judge Karen S. Marston currently oversees all proceedings. As of May 2026, approximately 3,636 cases are pending in this MDL.
Gastroparesis claims make up roughly 75% of the MDL 3094 case pool. The remaining cases involve ileus (intestinal blockage) and gallbladder injuries. A separate MDL 3163 handles vision loss claims. The litigation names both Novo Nordisk and Eli Lilly as defendants. Drugs at issue include Ozempic, Wegovy, Rybelsus, Trulicity, and Mounjaro.
| MDL | Court | Judge | Pending Cases | Primary Injury | Status |
|---|---|---|---|---|---|
| MDL 3094 | E.D. Pennsylvania | Karen S. Marston | 3,636 | Gastroparesis / GI Injuries | Daubert motions filed April 2026 |
| MDL 3163 | E.D. Pennsylvania | Karen S. Marston | 86 | NAION (Vision Loss) | Early discovery |
In August 2025, Judge Marston issued a landmark ruling. She refused to dismiss 12 of 17 counts against the manufacturers. However, she established that plaintiffs must prove their gastroparesis diagnosis through a properly performed gastric emptying study. Symptom-based claims alone are insufficient. This ruling makes medical documentation critical for every Ozempic gastroparesis lawsuit claim.
Eligibility and Evidence Requirements
To qualify for an Ozempic gastroparesis lawsuit, you generally need three things. First, documented use of a GLP-1 receptor agonist medication. Second, a gastroparesis diagnosis confirmed by a gastric emptying study (scintigraphy). Third, a timeline showing symptoms developed after starting the medication. The court’s August 2025 ruling made the scintigraphy requirement non-negotiable for viable claims.
Gather these records immediately. Pharmacy records showing when you filled Ozempic or similar prescriptions. Medical records documenting your gastroparesis diagnosis. Results from any gastric emptying studies you underwent. Hospital admission records for gastroparesis-related complications. Notes from your gastroenterologist confirming the condition. Records of any surgical interventions like feeding tube placement.
Special considerations apply to gastroparesis patients. If you had pre-existing mild gastroparesis that worsened dramatically after starting Ozempic, you may still qualify. The key question is whether the medication caused or significantly aggravated your condition. An experienced attorney can evaluate whether your specific circumstances meet the current legal standards for the Ozempic gastroparesis lawsuit.
Step-by-Step: How to Check If You Qualify
Step 1: Confirm you took a GLP-1 medication. Check your pharmacy records for Ozempic, Wegovy, Rybelsus, Mounjaro, Trulicity, or Zepbound. Note the exact dates you started and stopped. Step 2: Verify your gastroparesis diagnosis. You need documentation of a gastric emptying study (scintigraphy). Contact your gastroenterologist’s office to obtain these results. If you were diagnosed based on symptoms alone, ask your doctor about getting the proper test performed now.
Step 3: Establish your timeline. Document when your gastroparesis symptoms first appeared relative to starting the medication. Did nausea, vomiting, or stomach pain begin after you started Ozempic? Did existing mild symptoms become severe? Step 4: Document your damages. List every hospitalization, emergency room visit, lost workday, and medical expense related to your gastroparesis. Include feeding tube placement, nutritional therapy, and any permanent dietary restrictions.
Step 5: Consult a licensed attorney experienced in pharmaceutical litigation. Most mass tort attorneys offer free case evaluations. They can assess whether your evidence meets the current standards for an Ozempic gastroparesis lawsuit claim. Do not delay. Statutes of limitations apply, and early filing strengthens your position in the MDL.
Financial Considerations and Timeline
Most attorneys handling Ozempic gastroparesis lawsuit cases work on contingency. This means you pay nothing upfront. The attorney receives a percentage of any recovery, typically 33-40%. If you receive no compensation, you owe no attorney fees. This arrangement makes legal representation accessible regardless of your financial situation. Ask about case expenses and how they are handled.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
The litigation timeline requires patience. Expert depositions were completed in April 2026. Daubert motions challenging expert testimony were filed in late April 2026. Bellwether trials are expected in late 2026 or early 2027. A global settlement, if one occurs, likely will not materialize before late 2027. Total litigation value has been projected in the billions of dollars given the severity of injuries and number of plaintiffs.
Individual compensation varies significantly based on injury severity. Factors include duration of gastroparesis, need for surgical intervention, hospitalization frequency, lost income, and impact on quality of life. Patients with confirmed scintigraphy results and severe complications may receive higher valuations. No attorney can guarantee a specific outcome. Be wary of anyone who promises guaranteed compensation for your Ozempic gastroparesis lawsuit claim.
Finding the Right Attorney
Look for an attorney with specific experience in pharmaceutical mass tort litigation. Ask how many GLP-1 cases they currently handle. Ask whether they are involved in MDL 3094 leadership or steering committees. Attorneys with MDL involvement often have better access to shared discovery and case developments. Verify their track record with similar drug injury cases.
During your consultation, a qualified attorney should ask detailed questions about your medical history. They should request your gastric emptying study results. They should explain the current state of the Ozempic gastroparesis lawsuit litigation clearly. They should not pressure you into signing immediately. A good attorney understands that gastroparesis patients are already suffering. They should treat you with compassion and transparency.
Consider consulting multiple attorneys before choosing representation. Ask about communication frequency. Ask who will handle your case day-to-day. Larger firms may have more resources, but smaller firms may provide more personal attention. What matters most is finding someone who understands both the legal landscape and the medical reality of living with gastroparesis. You deserve an advocate who fights for your specific situation.
Frequently Asked Questions
Can I file an Ozempic gastroparesis lawsuit if I still take the medication?
Yes. You do not need to stop taking Ozempic to file a claim. However, discuss your treatment options with your prescribing physician. Your attorney needs documentation of your diagnosis regardless of whether you continue the medication. Many patients have already stopped due to severe side effects, but current use does not disqualify you from pursuing legal action.
What if my doctor diagnosed gastroparesis based on symptoms without a gastric emptying study?
The August 2025 court ruling requires scintigraphy confirmation for viable claims. If you only have a symptom-based diagnosis, ask your gastroenterologist to order a gastric emptying study as soon as possible. This test measures how quickly food leaves your stomach. Without it, your Ozempic gastroparesis lawsuit claim faces significant challenges under current court standards. Getting tested now can preserve your legal options.
How long do I have to file an Ozempic gastroparesis lawsuit claim?
Statutes of limitations vary by state. Most states allow two to three years from the date of injury or diagnosis. Some states use a “discovery rule” that starts the clock when you knew or should have known the medication caused your condition. Do not assume you have unlimited time. Consult a licensed attorney promptly to determine your specific deadline. Early filing also positions your case better within the MDL structure.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed May 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Pennsylvania Tort Reform Guide
- Georgia Tort Reform Guide
- New Jersey Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.